A leading oncologist has drawn attention to a major study that confirmed ivermectin is successful in treating multiple cancers after testing its use against 28 types of the disease.
The groundbreaking study was highlighted by Dr. William Makis MD, a renowned radiologist, oncologist, and cancer researcher.
The study was led by a team of researchers in Mexico led by Dr. Mandy Juarez.
According to Makis, the study’s paper is not available to the public but a summary can be viewed here.
The 2020 study is titled: “Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.”
Ivermectin was tested against 28 different forms of cancer.
The researchers sought to identify the effectiveness of using ivermectin as a cancer treatment.
The study found that ivermectin was successful in treating all of the cancers it was tested against.
While some cancers were more resistant to ivermectin than others, the drug still proved at least useful and also helped to improve the effectiveness of chemotherapy.
The most sensitive cancer cell lines were:
Ovarian Breast Glioblastoma Lung Cancer Colon Cancer Uterine SCC hepatocellular breast TNBC Pancreatic Endometrial
The least sensitive were:
osteosarcoma gastric